浙江海森药业股份有限公司

Zhejiang Haisen Pharmaceutical Co. Ltd.

Country: CN CDE+DMF+CEP VERY_HIGH

🇨🇳 CDE

10

10 products shown

🇺🇸 DMF

4

4 products shown

🇪🇺 CEP

4

4 products shown

Total

18

registrations

🇨🇳 CDE 注册 (10)

Product CAS Status Reg Number
Aminophenazone

氨基比林

58-15-1 Class A Y20190004242
Atorvastatin Calcium

阿托伐他汀钙

134523-00-5 Class A Y20190006109
Escitalopram Oxalate

草酸艾司西酞普兰

59729-33-8 Class A Y20190007282
Metamizole

安乃近

68-89-3 Class A Y20190003555
Parecoxib Sodium

帕瑞昔布钠

198470-84-7 Class A Y20170001457
Paroxetine

帕罗西汀

61869-08-7 Class A Y20230000065
Pazufloxacin

甲磺酸帕珠沙星

127045-41-4 Class A Y20190008648
Phenazone

安替比林

60-80-0 Class A Y20190006580
Propyphenazone

异丙安替比林

479-92-5 Class A Y20190006990
Sucralfate

硫糖铝

54182-58-0 Class A Y20190006042

🇺🇸 DMF 注册 (4)

Product CAS DMF Number Date
Atorvastatin Calcium

阿托伐他汀钙

134523-00-5 - 2010-10-25
Escitalopram Oxalate

草酸艾司西酞普兰

59729-33-8 - 2025-01-25
Paroxetine Hydrochloride Hemihydrate

帕罗西汀 盐酸盐

110429-35-1 - 2025-12-31
Sucralfate Non Sterile Bulk Drug Substance

硫糖铝

54182-58-0 - 2016-02-03

🇪🇺 CEP 注册 (4)

Product CAS CEP Number Date
Atorvastatin Calcium

阿托伐他汀钙

134523-00-5 CEP 2020-142 - Rev 02 -
Atorvastatin Calcium, Micronised 134523-03-8 CEP 2025-395 - Rev 00 -
Metamizole Sodium Monohydrate 5907-38-0 R1-CEP 2004-016 - Rev 03 -
Sucralfate

硫糖铝

54182-58-0 CEP 2019-185 - Rev 02 -

Source: cde+fda_direct; DMF高置信 | Updated: 2026-04-09 07:23:01